Atlas Trials

Efficacy and Safety of Jaktinib in Patients With COVID-19 Pneumonia.

Clinical trial NCT05672888 · UNKNOWN

Trial details

NCT number
NCT05672888
Sponsor
First Affiliated Hospital of Zhejiang University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
COVID-19 Pneumonia
Start date
2023-03-01
Primary completion
2024-01-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.